Strategy
Your data, distilled into a plan.
Findings across labs, wearables, genome, and medications, ranked by leverage. Owner, effort, and a clear validation window for each.
Plan progress
0 / 6
Top concern this week
Falling ferritin alongside lower HRV
Falling ferritin alongside lower HRV (H-001) · confidence 0.78
Ranked priorities
What matters most this week.
Tap to mark complete. Each item carries an owner and a validation window.
- Medical follow-upLow effortOwner · you + clinicianValidate in 56d
Ask your clinician about your falling ferritin
Why · Ferritin is at 14 ng/mL, below the lab's 30 floor, and has fallen on each draw for over a year. Your HRV has dropped over the same window. This is the strongest pattern in your data right now.
Next step · Bring the ferritin trend to your next visit. A question to ask: is iron worth checking as a factor in my lower HRV, and when would you re-test it?
- Ferritin 14 ng/mL (↓38%)
- HRV ↓11%
- RHR ↑2%
- NutritionLow effortOwner · you + clinicianValidate in 84d
Bring your vitamin D history to your next visit
Why · Your latest 25-OH vitamin D is 24 ng/mL, below the lab's 30 ng/mL floor. It has stayed between 19 and 26 across years of draws. You also carry GC and CYP2R1 variants linked to lower vitamin D levels.
Next step · Ask your clinician: what do you make of my vitamin D staying in the low 20s, given what is in my supplement log?
- 25-OH vit D 24 ng/mL
- GC + CYP2R1 variants
- SleepLow effortOwner · youValidate in 14d
Watch caffeine timing against your sleep
Why · Your CYP1A2 genotype is linked to slower caffeine clearance, so a 3pm coffee may still be active at bedtime. REM fragmentation on Oura has risen over the same window.
Next step · Try an earlier last coffee for two weeks and see whether your REM data changes.
- CYP1A2 slow metabolizer
- REM fragmentation ↑
- MovementMedium effortOwner · youValidate in 7d
Watch recovery before the next training block
Why · Strain rose 18% over baseline last week while recovery held at 72%, the floor of your green zone. Your HRV is already below your usual range.
Next step · A lighter week of easy cardio and mobility is one way to see whether HRV rebounds. If it climbs back above 65 ms, that tells you something about load.
- Strain 12.4 (↑18%)
- Recovery 72%
- HRV 58 ms
- Medical follow-upLow effortOwner · you + clinicianValidate in 84d
Ask your clinician about your rising TSH
Why · TSH has climbed from 1.6 to 4.5 mIU/L across your draws. The latest value sits just above the lab's range, and Free T4 is normal. The trend is the part worth discussing.
Next step · Ask your clinician: is my TSH trend worth following more closely, and would any other thyroid tests help at my next draw?
- TSH 4.5 ↑22%
- Free T4 normal
- Medical follow-upLow effortOwner · clinicianValidate in 180d
Bring breast-cancer polygenic load to your next OB-GYN visit
Why · Your BCAC313 polygenic score sits at the 78th percentile for your ancestry-matched cohort. It is one input among several, including family history, that clinicians weigh when they talk about screening.
Next step · Bring the genome dossier and ask: does this score change anything about my screening plan? No urgency. This is a long-term planning conversation.
- BCAC313 PGS · 78th %ile
- EUR-calibrated
Doctor visit · prep packet
Auto-generated questions to bring with you.
Each question is tied to specific data in your record. Print or share with your clinician.
Hematology
“My ferritin has dropped across my recent draws while my HRV fell. Is iron worth checking as a factor, and when would you re-test it?”
Why I’m asking · Ferritin is the clearest trend in my recent data, and I want to understand what it means for me.
- Ferritin 14 ng/mL (↓38% over 1y)
- Iron 64 µg/dL (low)
- Transferrin sat 16% (low)
Endocrinology
“TSH has been climbing across my panels (1.6 → 4.5 mIU/L) while Free T4 stays normal. What do you make of that trend, and is anything else worth testing?”
Why I’m asking · I'd like to know how closely to follow this and what would change the plan.
- TSH 4.5 mIU/L (climbing)
- Free T4 1.1 ng/dL (normal)
- Free T3 3.0 pg/mL (normal)
Pharmacogenomics
“I have a CYP2C19 *2/*2 poor-metabolizer result. How does that affect the medicines you might use for me, and can we note it in my chart?”
Why I’m asking · CPIC has a Level A guideline for this gene. Having it in my chart means any future clinician sees it.
- CYP2C19 *2/*2 poor metabolizer
- CPIC Level A guideline
Preventive
“My BCAC313 polygenic score for breast cancer is at the 78th percentile of my ancestry-matched cohort. Together with my family history, does it change anything about my screening plan?”
Why I’m asking · I'd rather plan ahead than react.
- BCAC313 PGS · 78th %ile · EUR
- Discuss family history at visit
Visit summary
Next routine appointment within 6–8 weeks ideal
6 findings, ranked. Top concern is ready to discuss.